Sponsorship of the Golf Event Continues
Following Horizon Acquisition
Golfers Shane
Lowry, Pádraig Harrington, Séamus Power and
Brendan Lawlor Will Become Amgen Golf Ambassadors
THOUSAND
OAKS, Calif., Dec. 14,
2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today
announced it will serve as the title sponsor of the Irish Open
starting in 2024, following the acquisition of Horizon Therapeutics
plc in October 2023. Horizon
Therapeutics, a leading Irish company, began sponsoring the
tournament in 2022 as part of a multi-year commitment to the Irish
community.
The 2024 Amgen Irish Open, part of the DP World Tour, will take
place at the Royal County Down Golf Club in Northern Ireland from Sept. 11-15, 2024. Amgen will also become a
partner to the KPMG Women's Irish Open.
Irish professional golfers Shane
Lowry, Pádraig Harrington, Séamus Power and
Brendan Lawlor served as golf
ambassadors on behalf of Horizon Therapeutics, and they will now
become Amgen golf ambassadors, wearing the Amgen logo while in
competition.
"Sponsorship of the Amgen Irish Open marks an important
milestone in Amgen's 25-year history in Ireland, and today's announcement further
demonstrates our commitment to the communities where our people
live and work," said Robert A.
Bradway, chairman and chief executive officer at Amgen. "We
are especially pleased to sponsor the Amgen Irish Open, recognizing
that the tournament contributes significantly to the Irish economy,
and is a source of national pride."
Amgen established a commercial presence in Ireland in 1998, and in 2011 it acquired a
manufacturing facility in Dun Laoghaire, which it has since
developed and upgraded with $1
billion in additional investment. Today Amgen employs
approximately 1,250 people in Ireland. Irish patient organizations supported
by Amgen include the Irish Osteoporosis Society, Multiple Myeloma
Ireland and CROÍ, a charity to prevent heart disease and stroke.
Award-winning biology education programs sponsored by the Amgen
Foundation have reached 500 science teachers and nearly 60,000
students across Ireland.
About Amgen
Amgen is committed to unlocking the potential of biology for
patients suffering from serious illnesses by discovering,
developing, manufacturing and delivering innovative human
therapeutics. This approach begins by using tools like advanced
human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and
leverages its expertise to strive for solutions that improve health
outcomes and dramatically improve people's lives. A biotechnology
pioneer since 1980, Amgen has grown to be one
of the world's leading independent biotechnology
companies, has reached millions of patients around the world and is
developing a pipeline of medicines with breakaway potential.
Amgen is one of the 30 companies that comprise the Dow
Jones Industrial Average and is also part of the Nasdaq-100 index.
In 2023, Amgen was named one of "America's Greatest Workplaces" by
Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best
Companies" by TIME.
For more information, visit Amgen.com and follow us on X
(formerly known as Twitter), LinkedIn, Instagram, TikTok,
YouTube and Threads.
CONTACT: Amgen, Thousand
Oaks
Jessica Akopyan, 805-440-5721
(media)
Justin Claeys, 805-313-9775
(investors)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amgen-to-sponsor-the-irish-open-302014797.html
SOURCE Amgen